REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea · Delayed Price · Currency is KRW 11,300
-290 (-2.50%)
Jan 30, 2026, 3:30 PM KST
REYON Pharmaceutical Market Cap
REYON Pharmaceutical has a market cap or net worth of 207.25 billion as of January 30, 2026. Its market cap has decreased by -15.42% in one year.
Market Cap
207.25B
Enterprise Value
412.95B
Revenue
149.34B
Ranking
n/a
PE Ratio
n/a
Stock Price
11,300.00
Market Cap Chart
Since June 10, 2010, REYON Pharmaceutical's market cap has increased from 164.55B to 207.25B, an increase of 25.95%. That is a compound annual growth rate of 1.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 207.25B | 4.82% |
| Dec 30, 2025 | 197.72B | -16.04% |
| Dec 30, 2024 | 235.50B | -22.37% |
| Dec 28, 2023 | 303.36B | -21.07% |
| Dec 29, 2022 | 384.35B | -39.10% |
| Dec 30, 2021 | 631.11B | 61.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AptaBio Therapeutics | 252.28B |
| Daewon Pharmaceutical | 250.13B |
| Samjin Pharmaceuticals | 240.50B |
| Chong Kun Dang Holdings | 235.41B |
| Ilyang Pharmaceutical Co.,Ltd | 233.92B |
| Suheung | 233.50B |
| Jeil Pharmaceutical Co.,Ltd | 217.41B |
| Samil Pharmaceutical Co.,Ltd | 198.92B |